FDA grants Orphan Drug Designation for ADXS-HPV in treatment HPV-linked … – News-Medical.net

FDA grants Orphan Drug Designation for ADXS-HPV in treatment HPV-linked
News-Medical.net
We will continue the ongoing Phase 1/2 study being coordinated by Brown University Oncology Group that is evaluating the safety and efficacy of ADXS-HPV when combined with standard chemotherapy and radiation treatment in patients with anal cancer.".

View full post on hpv – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *